1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes
(
- Contribution to journal › Article
- 2023
-
Mark
Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children
(
- Contribution to journal › Article
-
Mark
SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood
(
- Contribution to journal › Article
- 2022
-
Mark
Islet Autoantibody Type-Specific Titer Thresholds Improve Stratification of Risk of Progression to Type 1 Diabetes in Children
(
- Contribution to journal › Article
-
Mark
Islet Autoantibody Levels Differentiate Progression Trajectories in Individuals with Presymptomatic Type 1 Diabetes
(
- Contribution to journal › Article
-
Mark
Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectories
(
- Contribution to journal › Article
-
Mark
Elevations in blood glucose before and after the appearance of islet autoantibodies in children
(
- Contribution to journal › Article
- 2021
-
Mark
Imputing Longitudinal Growth Data in International Pediatric Studies : Does CDC Reference Suffice?
(
- Contribution to journal › Article
- 2019
-
Mark
Time-resolved autoantibody profiling facilitates stratification of preclinical type 1 diabetes in children
(
- Contribution to journal › Article
-
Mark
Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk : The GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol
(
- Contribution to journal › Article